- How vaping became a public health crisis (New York Magazine)
- The lucrative, largely unregulated, and widely misunderstood world of vaping (California Sunday Magazine)
- Nestle invests $200 million in Aimmune after peanut drug allergy approval (Reuters)
- Canadian antitrust officials probe farm giants (WSJ)
- From the archives (1986): Why Winnipeg makes a great test market (CBC)
Friday 7 February 2020
Stephan's Friday Picks
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment